BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Javed Z, Ahmed Shah F, Rajabi S, Raza Q, Iqbal Z, Ullah M, Ahmad T, Salehi B, Sharifi-Rad M, Pezzani R, Yaqoob F, Sadia H, Iriti M, Sharifi-Rad J, Cho WC. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer. Asian Pac J Cancer Prev 2020;21:281-7. [PMID: 32102500 DOI: 10.31557/APJCP.2020.21.2.281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Das PK, Asha SY, Abe I, Islam F, Lam AK. Roles of Non-Coding RNAs on Anaplastic Thyroid Carcinomas. Cancers (Basel) 2020;12:E3159. [PMID: 33126409 DOI: 10.3390/cancers12113159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yi D, Zhang D, He J. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis. Cell Cycle 2021;:1-19. [PMID: 34781815 DOI: 10.1080/15384101.2021.1995129] [Reference Citation Analysis]
3 Dadafarin S, Carnazza M, Islam HK, Moscatello A, Tiwari RK, Geliebter J. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis. Adv Exp Med Biol 2021;1350:145-55. [PMID: 34888848 DOI: 10.1007/978-3-030-83282-7_7] [Reference Citation Analysis]
4 Luzón-Toro B, Villalba-Benito L, Fernández RM, Torroglosa A, Antiñolo G, Borrego S. RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer. Orphanet J Rare Dis 2021;16:4. [PMID: 33407723 DOI: 10.1186/s13023-020-01665-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Javed Z, Khan K, Rasheed A, Sadia H, Raza S, Salehi B, Cho WC, Sharifi-Rad J, Koch W, Kukula-Koch W, Głowniak-Lipa A, Helon P. MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer. Front Pharmacol 2020;11:613464. [PMID: 33584291 DOI: 10.3389/fphar.2020.613464] [Reference Citation Analysis]
6 Javed Z, Khan K, Iqbal MZ, Ahmad T, Raza Q, Sadia H, Raza S, Salehi B, Sharifi-Rad J, Cho WC. Long non-coding RNA regulation of TRAIL in breast cancer: A tangle of non-coding threads. Oncol Lett 2020;20:37. [PMID: 32802161 DOI: 10.3892/ol.2020.11896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Golla U, Sesham K, Dallavalasa S, Manda NK, Unnam S, Sanapala AK, Nalla S, Kondam S, Kumar R. ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies. ncRNA 2022;8:21. [DOI: 10.3390/ncrna8020021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Peng S, Chen L, Yuan Z, Duan S. Suppression of MIR31HG affects the functional properties of thyroid cancer cells depending on the miR-761/MAPK1 axis. BMC Endocr Disord 2022;22:107. [PMID: 35443670 DOI: 10.1186/s12902-022-00962-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang B, Li Q, Song Z, Ren L, Gu Y, Feng C, Wang J, Liu T. hsa_circ_0000285 facilitates thyroid cancer progression by regulating miR-127-5p/CDH2. J Clin Lab Anal 2022;:e24421. [PMID: 35447001 DOI: 10.1002/jcla.24421] [Reference Citation Analysis]